BRAIN Biotech AG ( ETR:BNN ) shareholders will doubtless be very grateful to see the share price up 80% in the ...

In celebration of Global Biotech Week, the Bioscience Association Manitoba (BAM) will host a special event at the Manitoba ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

The results of the study show that treatment with Carragelose eye drops for four weeks significantly improves dry eye-related symptoms by 54%. Next to excellent tolerability, patients also reported a ...

Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners ...

Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

Invizius has raised £950,000 in a funding round led by Mercia Ventures and supported by Calculus Capital, Syensqo, the ...

Scott Rapoport earned his PhD in marine biology from Scripps Institution of Oceanography at UC San Diego in 2003. Drawn to ...

Vicebio has secured $100mn in Series B funding to further develop its vaccines for multiple respiratory infections.

The biotech sector is in good shape in 2024 and looks primed for sustained growth. These ASX stocks are looking to lead the way.